Nose K, Yang H, Sun X, et al
Yes, these drugs have been approved for type 2 diabetes treatment and weight loss
Patients with severe gastrointestinal disease , including gastroparesis, may not tolerate these medicines well due to their effect on gastric emptying
Meanwhile, GLP 1 receptors in hypothalamic and brainstem nuclei reduce hunger, enhance satiety and shift food preferences away from calorie-dense options
Peer review Peer review information Nature thanks Lucas Sullivan and the other, anonymous, reviewer(s) for their contribution to the peer review of this work
[PMID: 6722145] PubMed record related to this compound for laboratory literature review